AGIOS PHARMACEUTICALS, INC. (AGIO) Net income 2016–2025
AGIOS PHARMACEUTICALS, INC. (AGIO) annual net income history from SEC filings — each fiscal year as reported, with year-over-year change.
-$413.0MFY2025 · since FY2016: -$198.5M → -$413.0M
| Fiscal year | Value | YoY |
|---|---|---|
| FY2025 | -$413.0M | -161.3% |
| FY2024 | $674.0M | +291.5% |
| FY2023 | -$352.0M | -51.7% |
| FY2022 | -$232.0M | -114.5% |
| FY2021 | $1.6B | +590.3% |
| FY2020 | -$327.4M | +20.4% |
| FY2019 | -$411.5M | -18.9% |
| FY2018 | -$346.0M | -10.0% |
| FY2017 | -$314.7M | -58.5% |
| FY2016 | -$198.5M | — |
Source: SEC XBRL filings · For reference only · Not investment advice